Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Tetratherix Limited ( (AU:TTX) ) has provided an announcement.
Tetratherix Limited announced an investor webinar scheduled for September 1, 2025, following the release of its FY25 Results and Annual Report. The webinar will feature presentations from the company’s CEO, Co-Founder and CTO, and CFO, potentially impacting investor relations and providing insights into the company’s financial health and strategic direction.
The most recent analyst rating on (AU:TTX) stock is a Buy with a A$5.72 price target. To see the full list of analyst forecasts on Tetratherix Limited stock, see the AU:TTX Stock Forecast page.
More about Tetratherix Limited
Tetratherix Limited is a company specializing in the development of novel clinical products utilizing its patented biomaterial polymer platform technology.
Average Trading Volume: 58,474
See more data about TTX stock on TipRanks’ Stock Analysis page.